Guidelines: GEICAM Guidelines (Spain): Difference between revisions

From Beacon
m (Update categories.)
Line 23: Line 23:
<span style="display:none">availableVariable::screening</span>
<span style="display:none">availableVariable::screening</span>
<span style="display:none">hasCancerType::C50: Breast cancer</span>
<span style="display:none">hasCancerType::C50: Breast cancer</span>
<span style="display:none">isPracticeGuideline</span>

Revision as of 16:43, 4 December 2025

forproviders forpolicymakers Go back to Spain page

Primary purpose: To improve the clinical management of women with metastatic breast cancer in Spain by providing systematically developed recommendations for healthcare professionals, patients, and their families.

Sponsor, manager or home institution: GEICAM.

Type of information: medical procedures; cancer incidence; cancer prevalence; screening. Clinical questions to be addressed, methodology, diagnosis, various treatment options for metastatic breast cancer, management of specific metastatic locations, other relevant clinical situations, and follow-up and response evaluation.

Cancer Areas of Interest: C50: Breast cancer.

Access to information: Click here to access.

Lobular Breast Nipple Areola Ductal dataOwner::GEICAM availableVariable::medical procedures availableVariable::cancer incidence availableVariable::cancer prevalence availableVariable::screening hasCancerType::C50: Breast cancer isPracticeGuideline